Kava

Kava-kava, Awa, Ava, Yaqona, Sakau

Piper methysticum G.Forst.

Psychoactive Class

Anxiolytic Sedative GABAergic Muscle Relaxant Depressant

Chemical Class

Kava is a psychoactive beverage and herbal product derived from the rootstock of Piper methysticum, a tropical shrub native to the western Pacific.¹² It has been consumed in Pacific Island communities for over 3,000 years in social, ceremonial, and religious contexts.¹ Its active constituents, known as kavalactones, produce anxiolytic, sedative, and mildly euphoric effects often compared to alcohol without significant cognitive impairment.² The beverage characteristically causes a temporary numbing sensation in the mouth.³

Dosage & Duration

Dosage

Threshold~50 mg

Light50-70 mg

Moderate70-150 mg

Strong150-200 mg

Heavy300+ mg

Bioavailability

~50%

Doses refer to kavalactone content, not raw plant material; dried kava root contains approximately 3-20% kavalactones. Kava is known for reverse tolerance: repeated use over a break-in period may be required before full effects appear, and regular users may need less over time.

Duration

Onset20-30 minutes

Peak3-3 hours

After Effects9-18 hours

Total3-6 hours

Subjective Effects

The kava experience is a gentle, head-driven relaxation that removes the edge from anxiety while leaving mental lucidity largely intact, a combination frequently contrasted with the clouding intoxication of alcohol. Effects are strongly dose-dependent, ranging from mild relaxation, contentment, and increased sociability at lower amounts to heavy sedation, somnolence, and eventual sleep at high doses. A typical session begins with a subtle mood lift and talkativeness, deepens into calm bodily relaxation over the first one to two hours, and tapers gradually into tiredness, often ending in a deep, restful, dreamless sleep with no hangover the following morning.

Physical

The body feels warm, relaxed, and at ease, with muscle relaxation and a subtle physical numbness. Higher doses produce pronounced sedation and near-sleep drowsiness, and some users report a lazy, low-energy day following consumption.

Relaxation

Bodily relaxation is the core physical effect, easing the body after exertion and relieving fatigue.

Cognitive

The headspace is calm, content, and anxiety-free, described as a tranquil mood lift with mild euphoria and greater sociability. Mental clarity is preserved or even sharpened at moderate doses, with users remaining functionally unimpaired.

Emotional

The emotional tone is one of calm contentment and well-being, with a gentle, flowing mood lift.

Visual

Vision is not distorted; acuity and focus may feel mildly enhanced at moderate doses, and the eyes can become more sensitive to light.

Tactile

A mild, generalized numbing of the body accompanies the physical relaxation.

Reagent Testing

Loading reagent data

Expected colorimetric results are being prepared.

Pharmacology

Pharmacodynamics

Kava's pharmacological activity is primarily attributable to six major kavalactones (kavain, dihydrokavain, methysticin, dihydromethysticin, yangonin, and desmethoxyyangonin), which account for approximately 96% of the plant's pharmacological effects. The principal mechanism is potentiation of GABAA receptor activity, which has been attributed to alteration of lipid membrane structure and sodium channel function.⁴⁵ Several kavalactones also inhibit norepinephrine reuptake and possibly dopamine reuptake,⁴⁵ while all six act as reversible monoamine oxidase B (MAO-B) inhibitors.⁶ Additional mechanisms include CB1 cannabinoid receptor agonism by yangonin⁷ and blockade of voltage-gated sodium and calcium channels by kavain and methysticin.⁵

Pharmacokinetics

Kavalactones are rapidly absorbed from the gastrointestinal tract with variable bioavailability across individual compounds. In animal studies, kavain (the primary kavalactone in traditional preparations) showed an estimated oral bioavailability of approximately 50%.⁸ In humans, kavain undergoes extensive hepatic metabolism via cytochrome P450 (CYP) enzyme-mediated pathways, followed by phase II biotransformation processes including sulfonation, glucuronidation, and glutathione conjugation.⁸ In rats, over 90% of an administered kavain dose was eliminated within 72 hours through urine and feces, and no evidence of bioaccumulation has been observed in rats, mice, or humans.⁸

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

AnticoagulantsAntiplateletDissociativesHepatic Route drugsStimulants

TripSit

Tolerance

Full Tolerance

Kava is reported to produce reverse tolerance in many users, where repeated use may be needed before full effects are felt; some users do not experience this pattern.

Harm Potential

Addiction & Dependence

Psychological

Low

Traditionally regarded as non-addictive, especially compared to benzodiazepines. Some cases of psychological dependence have been documented in Pacific Island communities where heavy habitual use patterns similar to alcohol consumption have been observed.²³

Toxicity

Hepatic

Rare but serious liver disease cases have been documented, primarily associated with concentrated extracts using organic solvents, non-noble kava varieties, contamination with stems or leaves, or heavy chronic use; traditional water-based preparations of noble kava roots at moderate doses appear considerably safer.¹⁹

Dermatological

Heavy chronic use (31-440g powder per week) may cause 'kava dermopathy' characterized by dry, scaly skin on the palms, soles of feet, and back; this condition is reversible upon cessation of use.¹²¹

Systemic

Regular heavy use over extended periods has been associated with malnutrition, weight loss, mood disturbances, apathy, and increased susceptibility to infections; evidence for these effects remains limited and is confined to very heavy consumption patterns.³

Psychosis Risk

Those with endogenous psychoses are advised to avoid kava.

Seizure Risk

Seizures have been listed among possible adverse reactions from chronic heavy use; however, available evidence remains limited.¹⁴

History & Culture

Origins and Spread Through Oceania

Kava originated in northern Vanuatu, where it was domesticated by farmers approximately 3,000 years ago through selective cultivation.¹⁵ The plant was subsequently spread eastward by the Austronesian Lapita culture into the rest of Polynesia, becoming endemic to…

Legality

By Country

United StatesUnscheduled

Kava remains legal for sale, possession, and ingestion.¹ While the FDA previously raised concerns regarding potential liver toxicity,²² these remarks have since been archived and no scheduling action was taken. The substance is widely available in health food stores as liquid extracts and capsules.

BrazilLegal

Kava is sold in herb shops without specific regulatory controls. Recreational use is reportedly uncommon.

EthiopiaLegal

Kava products are available for purchase without age restrictions.

GermanyRestricted

Following multiple reported cases of liver toxicity, including fatalities and transplants, regulations were tightened.²⁰ Kava preparations are now required to be sold only in significantly diluted formulations.²⁰

NetherlandsBanned for sale

Kava-containing products have been prohibited from general sale since January 2003.

NorwayPrescription only

While not specifically scheduled as a controlled substance, the national health council classifies kava as a prescription medication due to its psychoactive properties, restricting availability to pharmacies only.

SwitzerlandRestricted

Kavalactone-containing pharmaceutical products such as Laitan have been banned from sale in pharmacies.

VanuatuRegulated (export quality)

As a major traditional producer, Vanuatu has enacted legislation focusing on regulating the quality of kava exports rather than restricting domestic availability.²³

AustraliaRegulated

Governed by the National Code of Kava Management since June 2007.¹⁷ Commercial importation is prohibited except for medical or scientific purposes.¹⁷ Individuals aged 18 or older may bring up to 2 kg in accompanied baggage for personal use.¹⁷

CanadaRestricted (commercial sale banned)

Health Canada issued a stop order in August 2002 prohibiting the sale of kava products for human consumption.¹⁸ All kava-containing products including beverages and supplements are banned from commercial sale. However, personal purchase and importation from foreign vendors is not illegal for Canadian citizens.

FranceBanned for sale

Kava supplements and products are prohibited from commercial sale.¹⁹ The raw plant Piper methysticum may reportedly still be available through herbalists.

IsraelUncertain

Legal status remains unclear due to conflicting reports. Kava may be legal to possess, import, and sell, but may also be prohibited.

New ZealandLegal

Kava supplements are widely available and sold at grocery stores without significant restriction.

SwedenBanned for sale (import permitted)

Commercial sale of kava within Sweden is prohibited. Personal importation for individual use is permitted.

United KingdomRestricted (medicinal products banned)

The 2002 UK Kava-kava Prohibition Order prohibits selling, supplying, or importing medicinal products that contain kava when intended for human consumption.²¹ Personal possession is still legal, and imports are permitted for purposes other than consumption.

References

Source Pages

Citations

Suggest an edit